Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology

被引:145
作者
Ehl, S [1 ]
Hombach, J [1 ]
Aichele, P [1 ]
Rülicke, T [1 ]
Odermatt, B [1 ]
Hengartner, H [1 ]
Zinkernagel, R [1 ]
Pircher, H [1 ]
机构
[1] Univ Zurich, Inst Expt Immunol, Dept Pathol, CH-8091 Zurich, Switzerland
关键词
D O I
10.1084/jem.187.5.763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the impact of various infectious and proinflammatory agents on the induction of peripheral T cell tolerance. Adoptive transfer of CD8(+) T cells from lymphocytic choriomeningitis virus (LCMV) T cell receptor transgenic mice into LCMV antigen transgenic mice expressing the LCMV glycoprotein epitope (gp) 33-41 under control of a major histocompatibility complex class I promoter led to efficient induction of peripheral tolerance after a period of transient activation. Ii, however, the recipient mice were challenged with viral or bacterial infections or proinflammatory agents (Lipopolysaccharide or Poly:IC) early after cell transfer, tolerance induction was prevented and instead, CD8(+) T cell activation leading to vigorous expansion and generation of cytolytic activity ensued. This became manifest in significant immunopathology mainly involving destruction of the splenic architecture and lysis of antigen-expressing lymphocyte and macrophage populations. Important parameters involved in the activation of host-reactive T cells by nonspecific infectious agents included the presence, localization, and quantity of the specific transgene-encoded self-antigen; in contrast, CD4(+) T cells were not required. In mice surviving the acute phase, the transferred CD8(+) T cells persisted at high levels in an anergic state; they were unable to generate cytolytic activity in vitro or to control LCMV infection in vivo. These results impinge on our understanding of the role of infectious agents in graft verus host reactions towards minor histocompatibility antigens.
引用
收藏
页码:763 / 774
页数:12
相关论文
共 51 条
[1]   Peptide antigen treatment of naive and virus-immune mice: Antigen-specific tolerance versus immunopathology [J].
Aichele, P ;
BrduschaRiem, K ;
Oehen, S ;
Odermatt, B ;
Zinkernagel, RM ;
Hengartner, H ;
Pircher, H .
IMMUNITY, 1997, 6 (05) :519-529
[2]   LONG-LIFE SPAN OF TOLERANT T-CELLS AND THE ROLE OF ANTIGEN IN MAINTENANCE OF PERIPHERAL TOLERANCE [J].
ALFERINK, J ;
SCHITTEK, B ;
SCHONRICH, G ;
HAMMERLING, GJ ;
ARNOLD, B .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) :331-336
[3]   The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice [J].
Baker, MB ;
Altman, NH ;
Podack, ER ;
Levy, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2645-2656
[4]   QUANTIFICATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS WITH AN IMMUNOLOGICAL FOCUS ASSAY IN 24-WELL OR 96-WELL PLATES [J].
BATTEGAY, M ;
COOPER, S ;
ALTHAGE, A ;
BANZIGER, J ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) :191-198
[5]   PERIPHERAL DELETION OF AUTOREACTIVE CD8(+) T-CELLS IN TRANSGENIC MICE EXPRESSING H-2K(B) IN THE LIVER [J].
BERTOLINO, P ;
HEATH, WR ;
HARDY, CL ;
MORAHAN, G ;
MILLER, JFAP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (07) :1932-1942
[6]  
Billingham R E, 1966, Harvey Lect, V62, P21
[7]   Virus-induced transient bone marrow aplasia: Major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus [J].
Binder, D ;
Fehr, J ;
Hengartner, H ;
Zinkernagel, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :517-530
[8]   Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease [J].
Braun, MY ;
Lowin, B ;
French, L ;
AchaOrbea, H ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :657-661
[9]   TERMINATION OF TOLERANCE TO HUMAN GAMMA-GLOBULIN IN MICE BY ANTIGEN AND BACTERIAL LIPOPOLYSACCHARIDE (ENDOTOXIN) [J].
CHILLER, JM ;
WEIGLE, WO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 137 (03) :740-750
[10]  
CLAMAN HN, 1963, J IMMUNOL, V91, P833